Thomas Ritter

9.7k total citations · 1 hit paper
141 papers, 7.2k citations indexed

About

Thomas Ritter is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Thomas Ritter has authored 141 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 47 papers in Immunology and 34 papers in Genetics. Recurrent topics in Thomas Ritter's work include Mesenchymal stem cell research (34 papers), Virus-based gene therapy research (29 papers) and Corneal Surgery and Treatments (29 papers). Thomas Ritter is often cited by papers focused on Mesenchymal stem cell research (34 papers), Virus-based gene therapy research (29 papers) and Corneal Surgery and Treatments (29 papers). Thomas Ritter collaborates with scholars based in Ireland, Germany and United States. Thomas Ritter's co-authors include Matthew D. Griffin, Aideen E. Ryan, Sweta Rani, Hans‐Dieter Volk, Oliver Treacy, Paul Lohan, Rhodri Ceredig, Michelle M. Duffy, Mary Murphy and Bernard P. Mahon and has published in prestigious journals such as Nature, Advanced Materials and Journal of Clinical Investigation.

In The Last Decade

Thomas Ritter

139 papers receiving 7.1k citations

Hit Papers

Mesenchymal Stem Cell-derived Extracellular Vesicles: Tow... 2015 2026 2018 2022 2015 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Ritter Ireland 41 3.1k 1.9k 1.8k 1.5k 740 141 7.2k
Ornella Parolini Italy 50 2.3k 0.7× 3.6k 1.9× 2.2k 1.2× 2.5k 1.7× 671 0.9× 192 8.2k
Toshio Nikaido Japan 49 2.9k 0.9× 842 0.4× 1.4k 0.8× 2.6k 1.8× 750 1.0× 132 8.7k
Alan T. Nurden France 60 2.0k 0.6× 1.4k 0.7× 1.4k 0.8× 2.9k 2.0× 473 0.6× 278 14.5k
Leslie E. Silberstein United States 43 2.8k 0.9× 1.5k 0.8× 2.8k 1.5× 888 0.6× 465 0.6× 116 7.9k
Peter Wernet Germany 50 3.2k 1.0× 2.8k 1.4× 3.9k 2.2× 2.3k 1.6× 604 0.8× 285 10.2k
Mark W. Majesky United States 48 5.4k 1.7× 1.5k 0.8× 1.1k 0.6× 2.4k 1.7× 1.3k 1.7× 100 10.0k
Pablo Menéndez Spain 52 5.1k 1.6× 1.2k 0.6× 706 0.4× 882 0.6× 922 1.2× 233 8.1k
Joo Youn Oh South Korea 37 1.5k 0.5× 2.2k 1.1× 868 0.5× 1.3k 0.9× 402 0.5× 175 6.1k
Hitoshi Okochi Japan 36 3.1k 1.0× 1.1k 0.6× 942 0.5× 1.2k 0.9× 453 0.6× 108 6.3k
Liying Zhang China 35 2.8k 0.9× 2.1k 1.1× 808 0.5× 1.5k 1.0× 1.5k 2.1× 198 7.2k

Countries citing papers authored by Thomas Ritter

Since Specialization
Citations

This map shows the geographic impact of Thomas Ritter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Ritter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Ritter more than expected).

Fields of papers citing papers by Thomas Ritter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Ritter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Ritter. The network helps show where Thomas Ritter may publish in the future.

Co-authorship network of co-authors of Thomas Ritter

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Ritter. A scholar is included among the top collaborators of Thomas Ritter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Ritter. Thomas Ritter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jiemin, et al.. (2025). Comparison of in-vitro immunomodulatory capacity between large and small apoptotic bodies from human bone marrow mesenchymal stromal cells. International Immunopharmacology. 153. 114480–114480. 1 indexed citations
2.
Bach, Thorsten, et al.. (2024). Healing the cornea: Exploring the therapeutic solutions offered by MSCs and MSC-derived EVs. Progress in Retinal and Eye Research. 105. 101325–101325. 5 indexed citations
3.
Utheim, Tor Paaske, Maria Notara, Dominique Brémond‐Gignac, et al.. (2024). Corrigendum to “Future directions in managing aniridia-associated keratopathy” [Surv Ophthalmol 68 (2023) 940–956]. Survey of Ophthalmology. 69(2). 300–301.
4.
Utheim, Tor Paaske, Maria Notara, Dominique Brémond‐Gignac, et al.. (2023). Future directions in managing aniridia-associated keratopathy. Survey of Ophthalmology. 68(5). 940–956. 13 indexed citations
5.
Wang, Jiemin, et al.. (2023). Immunomodulatory function of licensed human bone marrow mesenchymal stromal cell-derived apoptotic bodies. International Immunopharmacology. 125(Pt A). 111096–111096. 10 indexed citations
6.
O’Malley, Grace, Oliver Treacy, Kevin Lynch, et al.. (2018). Stromal Cell PD-L1 Inhibits CD8+ T-cell Antitumor Immune Responses and Promotes Colon Cancer. Cancer Immunology Research. 6(11). 1426–1441. 68 indexed citations
7.
Cabral, Joana, Shirley Hanley, Jared Q. Gerlach, et al.. (2017). Distinctive Surface Glycosylation Patterns Associated With Mouse and Human CD4+ Regulatory T Cells and Their Suppressive Function. Frontiers in Immunology. 8. 987–987. 33 indexed citations
8.
Lohan, Paul, Cynthia M. Coleman, Mary Murphy, et al.. (2014). Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned?. Stem Cell Research & Therapy. 5(4). 99–99. 60 indexed citations
9.
Liew, Aaron, Jill McMahon, Thomas Ritter, et al.. (2009). Comparison of Viral and Nonviral Vectors for Gene Transfer to Human Endothelial Progenitor Cells. Tissue Engineering Part C Methods. 15(2). 223–231. 17 indexed citations
10.
Ritter, Thomas & Uwe Pleyer. (2009). Novel gene therapeutic strategies for the induction of tolerance in cornea transplantation. Expert Review of Clinical Immunology. 5(6). 749–764. 9 indexed citations
11.
Rooney, Gemma E., Cathal J. Moran, Siobhán S. McMahon, et al.. (2008). Gene-Modified Mesenchymal Stem Cells Express Functionally Active Nerve Growth Factor on an Engineered Poly Lactic Glycolic Acid (PLGA) Substrate. Tissue Engineering Part A. 14(5). 681–690. 43 indexed citations
12.
Kuttler, Beate, Heike Wanka, Nora Klöting, et al.. (2007). Ex vivo gene transfer of viral interleukin‐10 to BB rat islets: no protection after transplantation to diabetic BB rats. Journal of Cellular and Molecular Medicine. 11(4). 868–880. 6 indexed citations
13.
Zenclussen, Ana Claudia, Katrin Gerlof, María Laura Zenclussen, et al.. (2005). Abnormal T-Cell Reactivity against Paternal Antigens in Spontaneous Abortion. American Journal Of Pathology. 166(3). 811–822. 458 indexed citations
14.
Pleyer, Uwe, Jun Yang, Heike Schäcke, et al.. (2005). Effects of a selective glucocorticoid receptor agonist on experimental keratoplasty. Graefe s Archive for Clinical and Experimental Ophthalmology. 243(5). 450–455. 4 indexed citations
15.
Kotsch, Katja, Josef Brock, Peter Nickel, et al.. (2004). FTY720 Prevents Anti-CD4 mAb-Induced Tolerance but Cannot Reverse Established Tolerance in a Rat Kidney Transplantation Model. American Journal of Transplantation. 4(6). 863–871. 6 indexed citations
16.
Ritter, Thomas, Manfred Lehmann, & Hans‐Dieter Volk. (2002). Improvements in Gene Therapy. BioDrugs. 16(1). 3–10. 77 indexed citations
17.
Hammer, Markus, Yuan Zhai, Masamichi Katori, et al.. (2001). Homing of In Vitro-Generated Donor Antigen-Reactive CD4+ T Lymphocytes to Renal Allografts Is α4β1 But Not αLβ2 Integrin Dependent. The Journal of Immunology. 166(1). 596–601. 11 indexed citations
18.
Ke, Bibo, Thomas Ritter, Hirohisa Kato, et al.. (2000). Regulatory Cells Potentiate the Efficacy of IL-4 Gene Transfer by Up-Regulating Th2-Dependent Expression of Protective Molecules in the Infectious Tolerance Pathway in Transplant Recipients. The Journal of Immunology. 164(11). 5739–5745. 47 indexed citations
19.
Ritter, Thomas, Guido Schröder, Athanasios Vergopoulos, et al.. (2000). Ischemia/reperfusion injury-mediated down-regulation of adenovirus-mediated gene expression in a rat heart transplantation model is inhibited by co-application of a TNFRp55-Ig chimeric construct. Gene Therapy. 7(14). 1238–1243. 13 indexed citations
20.
Lehmann, Manfred, et al.. (1999). Abolition of anti-CD4-induced allotransplantation tolerance by exogenous IL-2. Transplantation Proceedings. 31(1-2). 1220–1221. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026